𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Sex chromatin incidence and prognosis in breast cancer

✍ Scribed by Bozena Wacker; Charles P. Miles

Publisher
John Wiley and Sons
Year
1966
Tongue
English
Weight
484 KB
Volume
19
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Parity and prognosis in breast cancer
Parity and prognosis in breast cancer
✍ Angelos E. Papatestas; Dr Michael Mulvihill; Catherine Josi; John Ioannovich; Ge πŸ“‚ Article πŸ“… 1980 πŸ› John Wiley and Sons 🌐 English βš– 345 KB πŸ‘ 2 views

Analysis of five-year disease-free survival rates in 608 women with operable breast cancer revealed that the reproductive history is a significant prognostic determinant. Overall parous women had a significantly higher cumulative five-year disease-free survival rate (a%), compared to the nulliparous

Ethnicity and variation in breast cancer
Ethnicity and variation in breast cancer incidence
✍ Louise A. Brinton; Jacques Benichou; Marilie D. Gammon; Donna R. Brogan; Ralph C πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 French βš– 72 KB πŸ‘ 2 views

A breast cancer case-control study in Atlanta and 5 counties of central New Jersey involving interviews with 960 white and 281 black cases younger than 54 years of age enabled assessment of reasons for the varying incidence rates among these 2 ethnic groups. Of interest was why rates of breast cance

Estrogen receptors and long-term prognos
Estrogen receptors and long-term prognosis in breast cancer
✍ Dr. Steinar Aamdal; Ole B⊘rmer; Ole J⊘rgensen; Herman H⊘st; Gunnar Eliassen; Ola πŸ“‚ Article πŸ“… 1984 πŸ› John Wiley and Sons 🌐 English βš– 377 KB πŸ‘ 2 views

The long-term prognosis in 233 primary breast cancer patients, most of whom had received ovarian irradiation, has been related to the estrogen-receptor status of the primary tumors. The median observation time was 9 years. The receptor status did influence disease-free interval and survival only in